title: Potential toxicities of HIV therapeutics in the developing infant.
authors.affiliation: Division of Neurotoxicology, NCTR, Food and Drug Administration, Jefferson, Arkansas 72079-9502, USA. wslikker@nctr.fda.gov
authors.forename: W
authors.initials: W
authors.lastname: Slikker
authors.forename: O A
authors.initials: OA
authors.lastname: Olivero
authors.forename: T A
authors.initials: TA
authors.lastname: Patterson
authors.forename: M C
authors.initials: MC
authors.lastname: Poirier
mesh_terms: D000653:Amniotic Fluid / Q000378:metabolism; D000818:Animals; D019380:Anti-HIV Agents / Q000493:pharmacokinetics* / Q000633:toxicity*; D004247:DNA / Q000187:drug effects* / Q000378:metabolism*; D005260:Female; D005312:Fetal Blood / Q000378:metabolism; D005333:Fetus / Q000187:drug effects; D008253:Macaca mulatta; D008431:Maternal-Fetal Exchange; D010920:Placenta / Q000378:metabolism*; D011247:Pregnancy; D014018:Tissue Distribution; D015215:Zidovudine / Q000493:pharmacokinetics* / Q000633:toxicity
chemical_list: D019380:Anti-HIV Agents; D015215:Zidovudine; D004247:DNA